Mode
Text Size
Log in / Sign up

Equity-centered precision oncology framework addresses systemic disparities in pediatric and AYA cancer careNew Framework Aims to Improve Cancer Care for Young Adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the proposed equity-centered framework to address systemic disparities in pediatric and AYA cancer care.

This narrative review examines the precision oncology continuum for children, adolescents, and young adults (AYA) in both high-resource and low- and middle-income countries (LMICs). The authors identify significant disparities in survival and quality of life for these patients, which they attribute to delayed recognition, inadequate diagnostic capacity, fragmented referral pathways, treatment abandonment, and limited access to molecular diagnostics and survivorship services.

To address these inequities, the authors propose an equity-centered framework. This framework integrates foundational cancer services with progressively accessible molecular and digital technologies, regional referral networks, patient navigation, tele-oncology, and longitudinal cancer registries. The goal is to bridge the gap between biological precision and health-system precision to improve outcomes for AYA patients globally.

The authors note that this review is not an exhaustive country comparison. The findings are conceptual and provide a roadmap for systemic improvements rather than evidence from a primary trial. Clinical application of these findings depends on local infrastructure and the integration of multidisciplinary care and survivorship planning into existing health systems.

How this fits prior evidence

This narrative review addresses a gap in the current literature regarding the systemic barriers to equitable cancer care for children and adolescents. While previous coverage has focused on specific technical advancements such as intrathecal therapy for pain, ferroptosis-directed interventions for ICI resistance, and da Vinci robot-assisted surgery, this review focuses on the systemic infrastructure required to deliver precision oncology to AYA populations in low- and middle-income countries.

This review looks at how children, adolescents, and young adults (AYA) with cancer are treated across different countries. It highlights a significant gap in care between high-resource areas and low- or middle-income countries. These differences often stem from delayed diagnosis, limited access to advanced testing, and a lack of long-term support services.

To address these issues, experts suggest an equity-centered framework. This plan combines high-tech solutions, like molecular testing and digital tools, with stronger basic healthcare systems. The goal is to create a more consistent path for patients, including better referral networks and specialized care for survivors.

Because this is a narrative review of systems and concepts rather than a clinical trial, it does not provide specific medical results for individual patients. It serves as a roadmap for healthcare leaders to improve the quality of life and long-term outcomes for young cancer patients worldwide.

What this means for you:
A new framework aims to improve cancer care equity for young people by improving access to testing and support.

Common questions

What are the main challenges in cancer care for young people?

Children and young adults in low- and middle-income countries often face hurdles like delayed diagnosis, limited testing, and a lack of long-term support. These factors can lead to differences in survival and quality of life compared to those in high-resource areas.

How can the new framework improve treatment for young patients?

The proposed framework suggests combining basic healthcare improvements with advanced tools like molecular testing, tele-oncology, and better referral networks. This approach aims to provide more consistent care and better support for patients as they move through their treatment and into survivorship.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Cancer in children, adolescents, and young adults (AYA) remains a global health challenge, with disparities in survival and quality of life between high-resource and low- and middle-income countries (LMICs). These disparities arise across the cancer continuum, including delayed recognition, inadequate diagnostic capacity, fragmented referral pathways, treatment abandonment, limited supportive care, unequal access to molecular diagnostics, and insufficient survivorship services. Precision oncology provides an opportunity to address these challenges, but its equity potential extends beyond genomic sequencing and targeted therapies. This narrative review examines an integrated precision oncology continuum encompassing early recognition, diagnostic and pathological accuracy, molecular characterization, risk stratification, precision treatment, response monitoring, supportive care, and lifelong survivorship. Evidence from LMIC settings is used to illustrate diagnostic delay, referral barriers, treatment abandonment, health-system limitations, and outcome disparities without attempting an exhaustive country comparison. The review proposes a tiered, equity-centered framework in which foundational cancer services are strengthened alongside progressively accessible molecular and digital technologies. Regional referral networks, patient navigation, tele-oncology, pathology and laboratory networks, targeted molecular testing, multidisciplinary care, survivorship planning, and longitudinal cancer registries are emphasized as practical components. For AYA patients, fertility, reproductive health, mental health, education, employment, and transition between pediatric and adult services are incorporated into precision care. Ultimately, equitable precision oncology should connect biological precision with health-system precision, ensuring that every young person can receive timely diagnosis, appropriate treatment, continuous monitoring, and lifelong survivorship support.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.